NiveshIQNiveshIQ
NSE: DRREDDY  ·  Pharma

Dr. Reddy's Laboratories Ltd.

₹1,142.30▲ ₹6.70 (+0.59%)
Volume: 1,280,548Day Range: ₹1,131.10 – ₹1,147.8052W Range: ₹1,101.00 – ₹1,414.90
Price Chart  ·  Daily closes
1Y 6M 3M 1M 1W 1D
Sign up free to view full chart
⚡ Intelligence Signals 5 active
🟢 Bullish Earnings Catalyst 📊 RS Laggard (5D) 🔄 Sector Sweep ⚡ Signals Aligned 📉 Pullback

NiveshIQ has detected 5 active signals on DRREDDY. Sign up free to see what each signal means and how it affects the stock.

Unlock signals — free
Expected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Sign up to unlock expected move
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74 / 100
Sign up to unlock confidence score

About Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Limited is a leading integrated pharmaceutical company operating in North America, Europe, India, Russia, and internationally. The company's core business is driven by its Global Generics segment, which manufactures and markets prescription and over-the-counter finished pharmaceutical products. The segment also engages in the biologics business, while the Pharmaceutical Services and Active Ingredients (PSAI) segment manufactures and markets active pharmaceutical ingredients and intermediates. Dr. Reddy's has a strong presence in the Indian market, with a revenue of ₹33,593 Cr and a net income of ₹4,285 Cr. The company's recent Q1FY27 results showed a 6% decline in revenue, with the base business delivering strong double-digit growth. However, the profit fell 69% du

Financial Highlights

MetricFY24FY25FY26
Revenue₹28,012 Cr +13.50%₹32,643 Cr +16.50%₹33,700 Cr +3.20%
EBITDA Margin28.29%25.97%23.18%
Net Profit₹5,578 Cr +23.80%₹5,725 Cr +2.60%₹4,158 Cr -27.40%
EPS₹66.90₹67.77₹50.41

Annual figures in Indian Rupees (Crores). Source: BSE filings.

Analyst ConsensusConsensus target ₹1,336.30  |  Buy 17 · Hold 11 · Sell 12Sign in to see →

Recent News

🔒
+ 3 more stories about Dr. Reddy's Laboratories Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instant

Strategic Outlook

Management commentary highlights the importance of product launches, approvals, and therapy-mix improvement in driving t...

FY26 (last completed FY): revenue ₹33, 700 Cr, PAT ₹4, 158 Cr, EBITDA margin 23.2%, EPS ₹50.41. Year-on-year: revenue Yo...

🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instant

Everything you unlock with a free account

⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for DRREDDY
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track DRREDDY alongside your other holdings
Unlock full DRREDDY research — free
No credit card  ·  No trial  ·  Always free to start

Frequently Asked Questions

What AI signals does NiveshIQ provide for Dr. Reddy's Laboratories Ltd.?

NiveshIQ detects active intelligence signals for Dr. Reddy's Laboratories Ltd. (DRREDDY) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.

What are the key financials for Dr. Reddy's Laboratories Ltd.?

Dr. Reddy's Laboratories Ltd. operates in the Pharma sector with a market capitalisation of ₹10,782,102.7L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.

Does NiveshIQ provide investment advice?

No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.

Viewing preview of Dr. Reddy's Laboratories Ltd. — 5 active signals detected Unlock full analysis — free